Literature DB >> 1312714

Homodimerization and constitutive activation of the erythropoietin receptor.

S S Watowich1, A Yoshimura, G D Longmore, D J Hilton, Y Yoshimura, H F Lodish.   

Abstract

The erythropoietin receptor (EPO-R) is a member of the recently described cytokine receptor superfamily. A constitutively active (hormone independent) form of the EPO-R was isolated that has a single amino acid change in the exoplasmic domain, converting arginine-129 to cysteine (R129C). Since EPO-Rs containing R129S, R129E, and R129P mutations are functionally wild type, the presence of cysteine at residue 129, and not the loss of arginine, is required for constitutive activity. Several mutant forms of the EPO-R were analyzed; all constitutively active mutants form disulfide-linked homodimers, whereas EPO-responsive or inactive forms of the receptor do not. Monomers and disulfide-linked dimers of the constitutive receptor are present on the plasma membrane and bind EPO with a single affinity. Homodimerization of the EPO-R is likely to play a role in ligand-induced signal transduction, and disulfide-linked dimerization of the constitutive receptor may mimic this step.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312714      PMCID: PMC48612          DOI: 10.1073/pnas.89.6.2140

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Subunit promiscuity among hemopoietic growth factor receptors.

Authors:  N A Nicola; D Metcalf
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

2.  An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.

Authors:  G D Longmore; H F Lodish
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

3.  Purification and characterization of the receptor for murine granulocyte colony-stimulating factor.

Authors:  R Fukunaga; E Ishizaka-Ikeda; S Nagata
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

4.  Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor.

Authors:  K Hayashida; T Kitamura; D M Gorman; K Arai; T Yokota; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.

Authors:  A D D'Andrea; A Yoshimura; H Youssoufian; L I Zon; J W Koo; H F Lodish
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

6.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

7.  Mutational analysis of the ligand-binding domain of the prolactin receptor.

Authors:  M Rozakis-Adcock; P A Kelly
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule.

Authors:  B C Cunningham; M Ultsch; A M De Vos; M G Mulkerrin; K R Clauser; J A Wells
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

9.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.

Authors:  A Yoshimura; H F Lodish
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors.

Authors:  T Kitamura; N Sato; K Arai; A Miyajima
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

View more
  73 in total

Review 1.  Drugs for increasing oxygen and their potential use in doping: a review.

Authors:  Aurelie Gaudard; Emmanuelle Varlet-Marie; Francoise Bressolle; Michel Audran
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Authors:  Ke Liang; Francisco J Esteva; Constance Albarracin; Katherine Stemke-Hale; Yang Lu; Giampaolo Bianchini; Ching-Yi Yang; Yong Li; Xinqun Li; Chun-Te Chen; Gordon B Mills; Gabriel N Hortobagyi; John Mendelsohn; Mien-Chie Hung; Zhen Fan
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

3.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  DNA-dependent oligomerization of herpes simplex virus type 1 regulatory protein ICP4.

Authors:  Ruhul H Kuddus; Neal A DeLuca
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

5.  Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries.

Authors:  Hongkai Zhang; Ian A Wilson; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

6.  Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization.

Authors:  G Courtois; L Bénit; Y Mikaeloff; M Pauchard; M Charon; P Varlet; S Gisselbrecht
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.

Authors:  C Collesi; M M Santoro; G Gaudino; P M Comoglio
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

8.  The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface.

Authors:  J C Mulloy; R W Crownley; J Fullen; W J Leonard; G Franchini
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization.

Authors:  S S Watowich; D J Hilton; H F Lodish
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal.

Authors:  Sonia Salzano; Paola Checconi; Eva-Maria Hanschmann; Christopher Horst Lillig; Lucas D Bowler; Philippe Chan; David Vaudry; Manuela Mengozzi; Lucia Coppo; Sandra Sacre; Kondala R Atkuri; Bita Sahaf; Leonard A Herzenberg; Leonore A Herzenberg; Lisa Mullen; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.